Brain disorders are perhaps the most important unmet medical need today, yet developing effective new neurotherapeutics continues to challenge the life science industry. Biotechs are bringing innovative technologies to uncover the function and dysfunction of the brain at the molecular and cellular level in health and disease. Session attendees will hear from top leaders in the field of neuroscience as they discuss powerful new tools for identifying and validating targeted therapeutic strategies. Panelists will discuss how innovative approaches, including genomics, machine learning, physics, and RNA-based medicines, are creating programs that promise more personalized precision medicines and better clinical outcomes.